News
There is an unmet need for safe, effective, long-term therapies for autoimmune disorders. NIH inventors have isolated a population of mammalian cells comprising about 75% or higher B-1a regulatory cells (Bregs) and methods of preparation of such cell populations as a therapeutic for immune-related
Seven scientists in the United States and Britain who have come up with a revolutionary gene therapy cure for a rare genetic form of childhood blindness won the 2018 António Champalimaud Vision Award, a 1 million euro prize from Portugal’s Champalimaud Foundation. Among them is Michael Redmond
Scientists from the National Institute of Aging (NIA) at National Institutes of Health (NIH) in collaboration with Tawain's National Health Research Institutes and Case Western Reserve University School of Medicine worked with Peptron Inc. a Korean-based public pharmaceutical company to develop a